Insider Selling: Reckitt Benckiser Group Plc (RB) Insider Sells 13,701 Shares of Stock

Reckitt Benckiser Group Plc (LON:RB) insider Adrian Nevil Hennah sold 13,701 shares of Reckitt Benckiser Group stock in a transaction dated Friday, May 10th. The stock was sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97).

Shares of RB opened at GBX 6,175 ($80.69) on Wednesday. The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The stock has a market capitalization of $43.71 billion and a PE ratio of 20.26. Reckitt Benckiser Group Plc has a one year low of GBX 5,559 ($72.64) and a one year high of GBX 7,174 ($93.74).

The company also recently announced a dividend, which will be paid on Thursday, May 23rd. Stockholders of record on Thursday, April 18th will be paid a GBX 100.20 ($1.31) dividend. The ex-dividend date is Thursday, April 18th. This is an increase from Reckitt Benckiser Group’s previous dividend of $70.50. This represents a dividend yield of 1.67%. Reckitt Benckiser Group’s dividend payout ratio (DPR) is currently 0.66%.



Several research analysts have recently weighed in on RB shares. Royal Bank of Canada set a GBX 5,100 ($66.64) price objective on Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Wednesday, January 16th. Goldman Sachs Group set a GBX 6,820 ($89.12) target price on Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Thursday, May 2nd. UBS Group set a GBX 6,300 ($82.32) target price on Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Monday, February 25th. Jefferies Financial Group set a GBX 5,000 ($65.33) target price on Reckitt Benckiser Group and gave the company a “sell” rating in a research note on Monday, February 18th. Finally, Barclays started coverage on Reckitt Benckiser Group in a research note on Tuesday, March 26th. They issued an “overweight” rating and a GBX 7,500 ($98.00) target price for the company. Three research analysts have rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of GBX 7,117.78 ($93.01).

TRADEMARK VIOLATION WARNING: “Insider Selling: Reckitt Benckiser Group Plc (RB) Insider Sells 13,701 Shares of Stock” was originally posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://dakotafinancialnews.com/2019/05/15/insider-selling-reckitt-benckiser-group-plc-rb-insider-sells-13701-shares-of-stock.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: How Do Mutual Funds Work?

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.